Skip to content

AYURVEDA HERBAL MEDICINE FOR SICKLE CELL DISEASE IN CHILDREN

A RANDOMIZED COMPARATIVE CLINICAL STUDY ON SHARPUNKHADI A GRANULES AND SHARPUNKHADI GRANULES IN CHILDHOOD SICKLE CELL DISEASE

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064514
Enrollment
40
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs

Interventions

None listed

Sponsors

DR SIDDHI PATIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hb less than 11.5 and more than 6.5 Serum bilirubin less than 3 HbS more than 20 percent

Exclusion criteria

Exclusion criteria: Hb more than 11.5 and less than 6.5 Serum bilirubin more than 3 HbS less than 20 percent

Design outcomes

Primary

MeasureTime frame
Improvement in Hb Percentage Improvement in serum bilirubin Improvement in hepato and splenomegalyTimepoint: 30 and 60 days

Secondary

MeasureTime frame
Improvement in Quality of Life Improvement in ImmunityTimepoint: 30 and 60 days

Countries

India

Contacts

Public ContactDR SWAPNIL CR

PARUL INSTITUTE OF AYURVED

neonatecare2024@gmail.com9726587013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026